Research progress in the influence of EGFR genovariation on the clinical efficacy of gefitinib treatment of non-small cell lung cancer
As an epidermal growth factor receptor (EGFR) tyrosine kinase lung cancer-targeted drug, gefitinib has been widely applied in the treatment of non-small cell lung cancer (NSCLC). The present clinical application has shown that EGFR genovariation might cause the abnormal expression of lung cancer...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Editorial Board of Journal of Hainan Medical University
2018-02-01
|
| Series: | Journal of Hainan Medical University |
| Subjects: | |
| Online Access: | http://www.hnykdxxb.com/PDF/201802/39.pdf |